COSTANTE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 3.090
AS - Asia 1.767
EU - Europa 587
SA - Sud America 354
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 34
OC - Oceania 4
Totale 5.896
Nazione #
US - Stati Uniti d'America 2.995
SG - Singapore 798
CN - Cina 499
BR - Brasile 274
IT - Italia 211
IN - India 170
VN - Vietnam 169
SE - Svezia 133
GB - Regno Unito 85
CA - Canada 65
DE - Germania 64
AR - Argentina 37
HK - Hong Kong 27
MX - Messico 20
BD - Bangladesh 17
EC - Ecuador 14
ID - Indonesia 14
IR - Iran 13
UA - Ucraina 13
BE - Belgio 12
FI - Finlandia 11
JP - Giappone 10
RU - Federazione Russa 10
ZA - Sudafrica 10
IQ - Iraq 7
PL - Polonia 7
RO - Romania 7
UZ - Uzbekistan 7
CO - Colombia 6
ES - Italia 6
EU - Europa 6
PY - Paraguay 6
SA - Arabia Saudita 6
TR - Turchia 6
FR - Francia 5
MA - Marocco 5
NL - Olanda 5
CL - Cile 4
PE - Perù 4
TN - Tunisia 4
AU - Australia 3
CR - Costa Rica 3
EG - Egitto 3
KE - Kenya 3
PK - Pakistan 3
PT - Portogallo 3
UY - Uruguay 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
SN - Senegal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 5.843
Città #
San Jose 504
Chandler 444
Dallas 221
Ashburn 209
Singapore 192
Santa Clara 157
Bengaluru 142
Hefei 141
Princeton 137
Lawrence 135
Milan 132
Council Bluffs 123
Wilmington 92
Ho Chi Minh City 68
London 68
Chicago 65
Beijing 55
Ottawa 48
Des Moines 43
Munich 42
Hanoi 41
Shanghai 28
Hong Kong 27
Los Angeles 27
São Paulo 26
Guangzhou 19
Boardman 14
New York 14
Norwalk 14
Shenzhen 14
Brooklyn 13
Catania 13
San Francisco 13
Pune 10
Turku 10
Guayaquil 9
The Dalles 9
Da Nang 8
Redmond 8
Tokyo 8
Chennai 7
Haiphong 7
Horia 7
Jiaxing 7
Monterrey 7
Xi'an 7
Brussels 6
Columbus 6
Curitiba 6
Hanover 6
Johannesburg 6
Manaus 6
Merksem 6
Naples 6
Tashkent 6
Warsaw 6
Wuhan 6
Atlanta 5
Brasília 5
Quito 5
Rio de Janeiro 5
Thái Bình 5
Toronto 5
Wuxi 5
Belo Horizonte 4
Catanzaro 4
Guadalupe 4
Houston 4
Manchester 4
Phoenix 4
Porto Alegre 4
Redwood City 4
Rui'an 4
Seattle 4
Sumaré 4
Viamão 4
Ann Arbor 3
Baghdad 3
Bari 3
Belém 3
Bismarck 3
Boston 3
Bắc Ninh 3
Casablanca 3
Charlotte 3
Dongyang 3
Falls Church 3
Franca 3
Goiânia 3
Hangzhou 3
Lima 3
Marília 3
Milwaukee 3
Nairobi 3
Ninh Bình 3
Nova Iguaçu 3
Orem 3
Poplar 3
Rome 3
San Diego 3
Totale 3.606
Nome #
Hashimoto's thyroiditis and vestibular dysfunction 91
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 79
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 76
A novel double mutation val648ile and val804leu of ret proto-oncogene in multiple endocrine neoplasia type 2 76
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 76
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 74
Calcitonin as a biomarker of C cell disease: recent achievements and current challenges 71
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 70
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 68
Characterization of visual field alterations in patients with thyroid associated ophthalmopathy 64
Identification and optimal postsurgical follow-up of patients with very-low-risk papillary thyroid microcarcinoma 63
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study 62
Absence of circulating desialylated thyroxine-binding globulin in patients wiht hepatobiliary disease 61
Amiodarone 61
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 60
Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fcε receptor by a recombinant human autoantibody Fab converted to IgE 60
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 58
Alcune prospettive per la medicina clinica. La biologia molecolare 58
Multikinase inhibitors for the treatment of radioiodine refractory thyroid cancer: what have we learned from the 'real-world' experience? 58
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 58
Calcitonin screening in patients scheduled for thyroidectomy for nodular disorders. (e-letter) 57
Correlation between saccadic parameter variations and clinical evidences in thyroid autoimmune ophthalmopathy (TAO) affected patients 57
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 56
Absence of circulating desialylated thyroxine-binding globulin in patients with hepatobiliary disease 56
Amiodarone (letter) 55
Differentiated thyroid carcinoma: Defining new paradigms for postoperative management 55
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 54
Thyroid peroxidase autoantibody fingerprints: I. A cross sectional study in elderly women. J. Clin. Endocrinol. Metab 54
Recombinant human thyrotropin receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies 52
Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by an autoantibody Fab converted to IgE 51
The Natural History of Benign Thyroid Nodules 51
Recombinant thyroid peroxidase autoantibodies can be used for epitopic “fingerprinting” of thyroid peroxidase autoantibodies in the sera of individual patients 51
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivate 50
Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL-5 rat thyroid cells 50
Papillary thyroid cancer. Time course of recurrences during post-surgery surveillance. 49
Early diagnosis of compressive optic neuropathy (NOC) in patients with Thyroid Autoimmune Ophthalmopathy (TAO). 48
L-Tiroxina suppressive treatment has no beneficial effect on thyroid nodules after menopause 48
T4 antibodies and thyroxine-binding globulin (TBG) immunoradiometric assay 48
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy 47
Recombinant thyroid specific autoantibodies: II. Role of individual heavy and light chains in determining epitope recognition 47
hNIS protein in thyroid: the iodine supply influences its expression and localization 47
Iodine deficiency in Calabria: characterization of endemic goiter and analysis of different indicators of iodine status regionwide 47
Compressive optic neuropathy in patients with Thyroid Associated Ophthalmopathy 47
Slow growth of benign thyroid nodules after menopause: no need for long term thyroxine suppressive therapy in post-menopausal women 46
Algoritmo diagnostico delle malattie tiroidee 46
Effectiveness of L-Thyroxine treatment for the prevention of nodular goiter recurrence in an endemic goiter area 45
Low serum thyrotropin concentrations as a risk factor for Atrial Fibrillation in elderly patients 45
Calctonin and Carcinoembryonic antigen for the diagnosis and management of Medullary Thyroid Carcinoma. 45
Temporal changes in thyroid nodule volume: lack of effect on paranodular thyroid tissue volume 45
Early diagnosis of medullary thyroid carcinoma: Is systematic calcitonin screening appropriate in patients with thyroid nodular disease? 44
Tecnologia del DNA ricombinante nello studio delle malattie tiroidee autoimmuni. Identificazione della tireoperossidasi (TPO) 44
Early identification of a ret proto-oncogene somatic mutation in fine needle aspiration biopsy (FNAB) of a medullary thyroid carcinoma 44
Multiple Endocrine Neoplasia 2 44
Reproductive life and differentiated thyroid carcinoma in women: reciprocal influences on their respective outcome 43
The immunodominant region on human thyroid peroxidase recognized by autoantibodies does not contain the monoclonal antibody 47/c21 linear epitope 43
Neck ultrasonography in the follow-up of low risk patients with papillary thyroid cancer (PTC) 43
Predictive value of serum Calcitonin levels for preoperative diagnosis of Medullary Thyroid Carcinoma in a cohort of 5817 consecutive patients with thyroid nodules 43
hNIS protein in thyroid: the iodine supply influences its expression and localization. Thyroid 43
Follow-up of low-risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases 43
Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis. 42
Thyroid carcinoma and thyrotoxicosis 42
Un raro caso di morbo di Basedow monolaterale intollerante al trattamento con tionamidi 42
Subclinical optic nerve involvement in patients with thyroid-associated ophthalmopathy 42
Effects of active immunization against l-triiodothyronine on serum thyrotropin and liver alpha-glycerophospate dehydrogenase activity in rats: evidence for reduced hormone disposal to cells 41
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas 41
Ruolo aritmogeno dell’ipertiroidismo subclinico: bassi livelli di TSH come fattore di rischio per la comparsa della fibrillazione atriale nei soggetti anziani 41
Screening Leading to Diagnosis of C-Cell Hyperplasia 41
Ruolo dell’ecografia del collo nel follow-up a 5 anni dei pazienti affetti da carcinoma papillifero della tiroide a basso rischio 41
Lack of relationship between cAMP desensitization and TSH receptor down-regulation in the rat thyroid cell line FRTL5 41
Thyroid diseases in the fetus 40
Metformin therapy decreases serum TSH levels in patients submitted to L-thyroxine treatment 40
Low serum Thyrotropin concentrations as a risk factor for atrial fibrillation in elderly subjects 40
Circulating immunoglobulin E (IgE) antibodies to l-thyroxine in a euthyroid patient with multinodular goiter and allergic rhinitis 39
Papillary thyroid carcinoma in struma ovarii 39
Failure to find evidence of immunoglobulin inhibitor(s) of thyroid hormone binding protein in non-thyroid illnesses 39
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: Is there a role for serum thyroglobulin measurement? 39
Fibrillazione atriale nei soggetti anziani: ruolo aritmogeno dell’ipertiroidismo subclinico 39
Specific autoantibody binding to thyroid peroxidase: dominant role of the light chain in determining epitope recognition 39
Thyroid hormones regulate red blood cell Ca2+-dependent ATPase activity through a "non hormonal" mechanism 39
Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study 39
Screening leading to C cell hyperplasia 39
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas 38
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. 38
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates 38
In vitro effects of thyroid hormones on red blood cell Ca2+-dependent ATPase activity 38
Recurrence of nodular goiter: evidence for a prophylatic role of postoperative L- Tiroxine treatment in a moderate iodine deficiency area 38
Long lasting prophylaxis of iodine deficiency after a successful information campaign for iodized salt consumption 37
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies. 37
Correlazione tra le modifiche dei parametri saccadici e le manifestazioni cliniche nei pazienti con oftalmopatia tiroidea autoimmune 37
Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas 37
IODINE STATUS IN INDIVIDUALS: AN ITALIAN PERSPECTIVE 36
HbA1c levels in patients with gestational diabetes mellitus: relationship with pre-pregnancy body mass index and pregnancy outcome. 35
Stimulation of liver mitochondrial alpha-glycerophosphate dehydrogenase activity by l-thyroxine in thyroidectomized rats: comparison with the suppression of pituitary TSH secretion 35
Recombinant thyroid peroxidase autoantibodies: I. How diverse is the pool of heavy and light chains in immunoglobulin gene libraries constructed from thyroid tissue infiltrating plasma cells? 35
Identification and characterization of circulating thyroid.hormone binding auto-antibodies in thyroid disease, in autoimmune non thyroid illnesses and lymphoreticular system disorders 35
SUBCLINICAL VISUAL FIELD ALTERATIONS IN THYROID ASSOCIATED OPHTHALMOPATHY PATIENTS 35
Thyroglobulin in fine needle aspirate—a clue to metastasis? 35
Novel therapeutic options for radioiodine-refractory thyroid cancer: Redifferentiation and beyond 35
Identification of a Neck Lump as a Lymph Node Metastasis from an Occult Contralateral Papillary Microcarcinoma of the Thyroid: Key role of Thyroglobulin Assay in the Fine needle Aspirate 34
Isolation and characterization of a monoclonal human thyroidperoxidase autoantibody of lambda light chain type 34
Totale 4.799
Categoria #
all - tutte 63.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022386 0 1 4 89 46 5 10 87 30 28 68 18
2022/20231.107 277 58 10 110 131 95 1 106 198 61 48 12
2023/2024288 78 35 29 16 15 87 10 4 0 1 4 9
2024/20251.246 190 123 91 55 52 160 9 34 166 79 73 214
2025/20262.550 88 322 301 469 285 73 356 184 296 115 33 28
2026/2027168 41 127 0 0 0 0 0 0 0 0 0 0
Totale 5.896